The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Saxenda contains liraglutide, which is a GLP-1 receptor agonist. Liraglutide helps promote weight loss by decreasing appetite and slowing the emptying of the stomach, which promotes feelings of ...